Table 1 Summarized clinical data of the clival and sacral chordoma patients.

From: HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas

Patient

Localisation

Age at diagnosis

Gender

Tumour Size (cm)

Histological subtype

Ki-67

Metastases

Recurrences

R-Status

C1

Clivus

35

male

0.4

NOS

≤10%

R2

C2

Clivus

45

female

2.3

NOS

≤10%

Rx

C3

Clivus

49

female

0.9

NOS

≤10%

R2

C4

Clivus

81

male

1.4

NOS

≤10%

R2

C5

Clivus

79

male

1.7

NOS

≤10%

R2

S1

Sacrum

60

female

12

NOS

≤10%

Rx

S2

Sacrum

78

female

18

NOS

≤10%

R1

S3

Sacrum

50

female

10

NOS

≤10%

R0

S4

Sacrum

74

male

7

NOS

≤10%

Rx

S5

Sacrum

45

female

7

NOS

≤10%

1

R1

S6

Sacrum

68

male

6

NOS

≤10%

1

R1

S7

Sacrum

69

female

17

NOS

≤10%

1

R1

S8

Sacrum

45

male

20

NOS

≥10%

1

1

R1

S9

Sacrum

70

female

13.6

NOS

≤10%

1

R0

S10

Sacrum

76

female

6

NOS

≤10%

1

1

R0

S11

Sacrum

74

female

13

NOS

≤10%

1

R1

S12

Sacrum

71

female

18

NOS

≤10%

1

R1

S13

Sacrum

70

male

3

NOS

≤10%

1

R2

S14

Sacrum

67

male

6

NOS

≥10%

1

>1

Rx

S15

Sacrum

75

male

6.5

NOS

≤10%

1

R1

S16

Sacrum

49

male

5.2

NOS

≥10%

>1

>1

NA

S17

Sacrum

77

male

2.5

NOS

≤10%

1

1

R2

S18

Sacrum

78

female

5.1

NOS

≤10%

1

R1

S19

Sacrum

54

male

4.5

NOS

≥10%

1

R2

S20

Sacrum

47

male

2

NOS

≤10%

R2

S21

Sacrum

29

male

2.9

NOS

≤10%

1

R1

S22

Sacrum

71

male

8

NOS

≤10%

R0

S23

Sacrum

83

male

50

NOS

≥10%

R2

S24

Sacrum

79

female

15

NOS

≤10%

R0

  1. NOS not otherwise specified, R-Status residual tumour status, R0 no residual tumour, R1 tumour cells detected microscopically at the resection margin, R2 macroscopic detectable residual tumour, Rx R-status uncertain.